Abstract:Over the past several years, numerous studies investigated the anti-inflammatory effects of statin on patients with RA. However, the findings of the individual studies were often inconsistent or conflicting.The Pubmed, Web of Science, Embase, Cochrane Library and CNKI literature databases were searched in order to identify randomized controlled clinical trials where the association between the anti-inflammatory effect of statin and RA was investigated. Two researchers performed data extraction from eligible independently. Quality parameters and risk of bias in the included studies were assessed according to Cochrane's guidelines. The pooled Standardized Mean Difference (SMD) with a 95%CI was used to assess the anti-inflammatory effect of statin in patients with RA.Fifteen randomized controlled clinical, classified as "high quality" and with a relatively low risk of selection bias, were included in the meta-analysis. Of these, eight reported that there was no difference in the level of serum total lipids between the atorvastatin-treated and the conventional treatment group. However, the pooled analysis showed that atorvastatin could increase the level of serum amount of high-density lipoprotein (HDL) in RA patients by approximately x ± SD95% [HDL: SMD = 0.807, 95%CI = (0.187, 1.426), p = .011]. Meanwhile atorvastatin could reduce the level of serum low-density lipoprotein (LDL), total cholesterol (TC), and triglyceride (TG) in RA patient by x ± SD95% [LDL: SMD = -4.015, 95%CI = (-5.848, -2.183), p = .000; TC: SMD = -4.497, 95%CI = (-6.457, -2.537), p = .000; TG: SMD = -1.475, 95%CI = (-2.352, -0.599), p = .001]. Nine studies reported a change in C-Reactive Protein (CRP) after atorvastatin treatment, and the pooled analysis showed that atorvastatin decreased CRP in RA patients by x ± SD95% [SMD = -3.033, 95%CI = (-4.460, -1.606), p = .000]. Seven studies investigated the change of Erythrocyte Sedimentation Rate (ESR), and the pooled analysis showed that atorvastatin decreased ESR by x ± SD95% [SMD = -2.097, 95%CI = (-3.408, -0.786), p = .002]. Nine studies reported the improvement of disease activity score in RA patients after taking atorvastatin for 12 weeks, and the pooled analysis showed atorvastatin could decrease the DAS28 score in RA patients by x ± SD95% [SMD = -2.001, 95%CI = (-3.191, -0.811), p = .001].Statins have a significant anti-inflammatory effect in RA patients. However, atorvastatin was superior to simvastatin both in terms of its anti-inflammatory and lipid-lowering activities.

Anti-inflammatory Properties of Statins

Overview of Therapeutic Effects of Statins on Inflammatory Diseases Through Regulating Adhesive Molecules

Overview of therapeutic effects of stains on inflammatory diseases through regulating adhesive molecules.

Effect of statin administration on the inflammatory response of monocytes in patients with atherosclerosis

Anti-inflammatory Effect of Statins in Pulmonary Disease

Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways

Effects of Fluvastatin Therapy on Serum Interleukin-18 and Interleukin-10 Levels in Patients with Acute Coronary Syndrome

The Influence of Statins on the Blood Inflammatory Factors and Fatty Acid of Erythrocyte Membrane Inhypercholesterolemic Patients.

The Anti-Inflammatory Effects of Statins on Patients with Rheumatoid Arthritis: A Systemic Review and Meta-Analysis of 15 Randomized Controlled Trials

Atheroprotective Effects of Statins in Patients with Unstable Angina by Regulating the Blood-Borne Microrna Network

Rosuvastatin Alters the Proteome of High Density Lipoproteins: Generation of alpha-1-antitrypsin Enriched Particles with Anti-inflammatory Properties

Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis

Rosuvastatin enhances anti-inflammatory and inhibits pro-inflammatory functions in cultured microglial cells

Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium.

The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome.

The effect of lipid-lowering therapies on the pro-inflammatory and anti-inflammatory properties of vascular endothelial cells

Myocardial Expression of Pluripotency, Longevity, and Proinflammatory Genes in the Context of Hypercholesterolemia and Statin Treatment

Effect of Simvastatin on Serum Level of Inflammatory Factors in Acute Coronary Syndrome

Direct Proinflammatory Effect of C-reactive Protein on Human Monocytes Isolated from Patients with Acute Coronary Syndrome and Statins Intervention

Statin Function As an Anti-inflammation Therapy for Depression in Patients with Coronary Artery Disease by Downregulating Interleukin-1β.

Effect of Statins on Prevention and Treatment for Chronic Obstructive Plumonary Diseases